Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 452 of 5804
-
Weight-Loss drug semaglutide takes on atrial fibrillation in new trial
Disease control Recruiting nowThe goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard A…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Weekly HIV pill could replace daily doses
Disease control OngoingInvestigators are trying to find better treatments for people with HIV-1. In this clinical study, investigators want to see how well a new treatment called ISL+ULO, taken once a week, works compared to an existing treatment called BIC/FTC/TAF, which is taken every day. Investigat…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Arm cuff may boost brain recovery after stroke: major trial underway
Disease control Recruiting nowA substantial body of basic and clinical research has demonstrated the protective effects of remote ischemic conditioning (RIC) in ischemic stroke. While these clinical studies support the safety of RIC, the neuroprotective benefits of RIC in acute ischemic stroke (AIS) patients …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis is a Phase 2, open-label, global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers.
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New imaging agent aims to unmask hidden prostate cancer recurrences
Diagnosis Recruiting nowThis phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer in patients who have increasing prostate-specific antigen levels following prior treatment (biochemical recurrence) but wh…
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New drug JS212 aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study is a Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects with Advanced Malignant Solid Tumour. Patients will be enrolled in two stages: a dose-escalation stage and a dose expansion stage.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a second dose of this radioactive drug beat back prostate cancer again?
Disease control Recruiting nowProstate cancer is the third leading cause of cancer-related death in men in the United States and Europe. The treatment of metastatic castration-resistant prostate cancer (mCRPC) has evolved with the arrival of the radioligand \[177Lu\]Lu-PSMA-617, which specifically targets PSM…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New heart lead could improve pacing for thousands with heart failure
Disease control OngoingThis is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at u…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New heart mapping technique aims to stop Life-Threatening rhythms
Disease control Recruiting nowVentricular tachycardia (VT) is a life-threatening heart rhythm disorder. Special pacemakers called implantable cardiac defibrillators (ICDs) help treat VT episodes, however they do not prevent the VT episodes from occurring. Catheter ablation for VT is a minimally-invasive and e…
Phase: NA • Sponsor: University Hospitals Coventry and Warwickshire NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for bladder cancer: trial pits top drugs against each other
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be compared to usual care with other NCCN-recommended standard treatments for NMIBC (…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Dissolvable stent could save legs from amputation
Disease control Recruiting nowThe objective of this prospective, single-blinded, randomized controlled trial is to evaluate the safety and efficacy of the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Approximately 276 subjects will be randomized in a 1:1 ratio. The clinic…
Phase: NA • Sponsor: R3 Vascular Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for blood cancer: targeted therapy combo shows promise in phase 2 trial
Disease control Recruiting nowResearchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that affects young B-cells that are still maturing. The goal of this study is to lea…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Ancient grain, modern hope: foxtail millet muffins may tame blood sugar in obesity
Disease control CompletedThis randomized controlled trial evaluated the effectiveness of foxtail millet (Setaria italica (L.) P. Beauv.) muffin supplementation on postprandial glycemic management among obese patients with type 2 diabetes mellitus. A total of 102 participants aged 30-60 years were randoml…
Phase: NA • Sponsor: University of Lahore • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Experimental triple therapy targets tough childhood liver cancer
Disease control Recruiting nowThis study is a single-cohort study. Pediatric patients with advanced, relapsed/refractory hepatoblastoma who have previously failed first-line or higher systemic therapy will receive 2 cycles of treatment with sintilimab combined with lenvatinib and chemotherapy (irinotecan). Pa…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for tough chest tumors: targeted radiation trial launches
Disease control ENROLLING_BY_INVITATIONTo evaluate the safety and efficacy of Boron Neutron Capture Therapy (BNCT) in patients with recurrent thoracic solid tumors that are difficult to treat with standard radiation therapy or drug therapy and are unresectable. With "lung," "heart," "liver," "spinal cord," and "esopha…
Phase: PHASE1, PHASE2 • Sponsor: Stella Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New heart catheter aims to zap dangerous rhythms safely
Disease control Recruiting nowThe VISABL-VT is a prospective, single-arm, multi-center, interventional investigation of the safety and efficacy of radiofrequency (RF) ablation of ventricular tachycardia associated with ischemic cardiomyopathy performed with the Vision-MR Ablation Catheter 2.0 in the iCMR envi…
Phase: NA • Sponsor: Imricor Medical Systems • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for rare blood cancer: phase 3 trial of XNW5004 launches
Disease control Recruiting nowThis is a randomized, double-blind, multi-center, phase III clinical trial designed to evaluate the efficacy of XNW5004 tablets versus Chidamide in Relapsed/Refractory PTCL, with a target of enrolling 120 subjects.
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a monthly shot stop fentanyl overdoses in cocaine and meth users?
Prevention Recruiting nowThe goal of this clinical trial is to see if an injectable medicine called naltrexone can prevent fentanyl overdose deaths in people who use other drugs (cocaine, methamphetamine). The main questions it aims to answer are: What are the challenges for implementing naltrexone as a…
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Radiation and immunotherapy join forces against Hard-to-Treat liver metastases
Disease control Recruiting nowTo explore the efficacy and safety of stereotactic body radiation therapy (SBRT) combined with PD-1 monoclonal antibody in the treatment of unresectable colorectal cancer liver metastasis through a prospective study, providing high-level evidence-based medical evidence for the us…
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New antibody IBI311 takes on steroids in Head-to-Head trial for thyroid eye disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:13 UTC